News

Filter

1 to 9 of 10 results

Orexo gets £5 million milestone for Abstral in Europe; Zubsolv continues strong growth in the USA

Orexo gets £5 million milestone for Abstral in Europe; Zubsolv continues strong growth in the USA

18-12-2014

The annual sales in Europe of Abstral, a rapidly-disintegrating, sublingual formulation of fentanyl,…

AbstralFinancialKyowa Hakko KirinLicensingNeurologicalOrexoPharmaceuticalProStrakanZubsolv

Kyowa Hakko and LEO Pharma partner on topical calcipotriol/betamethasone dipropionate in Japan

26-12-2013

Japanese drugmaker Kyowa Hakko Kirin and Denmark’s privately-held dermatology specialist LEO Pharma…

Asia-PacificBetamethasone DipropionatecalcipotriolDermatologicalsKyowa Hakko KirinLEO PharmaLicensingMarkets & MarketingPharmaceutical

ProStrakan initiates EU launch of Sancuso

30-09-2013

ProStrakan has started the European Union roll-out of its transdermal patch Sancuso for the prevention…

BiotechnologyEuropeKyowa Hakko KirinLicensingOncologyProStrakanSancuso

Kyowa Hakko Kirin collaborates with Ultragenyx on KRN23

06-09-2013

Japanese mid-sized drugmaker Kyowa Hakko Kirin (TYO: 4151) has entered into a collaboration and license…

BiotechnologyKRN23Kyowa Hakko KirinLicensingPharmaceuticalRare diseasesResearchUltragenyx

Drug discovery alliances for Boehringer and Horizon Discovery; and NovAliX with Kyowa Hakko

15-01-2013

UK-based Horizon Discovery, a provider of research tools to support the development of personalized medicines,…

Boehringer IngelheimHorizon DiscoveryKyowa Hakko KirinLicensingNovAliXOncologyPharmaceuticalResearch

Kyowa Hakko Kirin returns rights to Busulfex to Otsuka

17-09-2012

Japanese drugmaker Kyowa Hakko Kirin (TYO: 4151) has reached agreement on returning development and marketing…

BusulfexKyowa Hakko KirinLicensingOncologyOtsukaPharmaceutical

Otsuka sells on Japanese saxagliptin rights to Kyowa Hakko

03-07-2012

Japanese drugmakers Otsuka Pharmaceutical (TYO: 4578) and Kyowa Hakko Kirin (TYO: 4151) have entered…

Asia-PacificBristol-Myers SquibbDiabetesKyowa Hakko KirinLicensingOncologyOtsukaPharmaceuticalResearchsaxagliptin

1 to 9 of 10 results

Back to top